The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Bayko Liisa Ann | Chief Financial Officer | Grant(A) | 220K | — | $0 |
| Jun 3, 2026 | Patterson Leone D | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Hallal David | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Akkaraju Srinivas | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Dybbs Michael | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Adamis Anthony P | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Jovan-Embiricos Morana | Director | Grant(A) | 9K | — | $0 |
| Jun 3, 2026 | Ferrara Napoleone | Director | Grant(A) | 9K | — | $0 |
| May 20, 2026 | Akkaraju Srinivas | Director, 10% Owner | Buy(P) | 244K | $4.83 | $1.2M |
| May 20, 2026 | Akkaraju Srinivas | Director, 10% Owner | Other(J) | 67K | — | $0 |
| May 20, 2026 | Akkaraju Srinivas | Director, 10% Owner | Other(J) | 15K | — | $0 |
| May 20, 2026 | Akkaraju Srinivas | Director, 10% Owner | Other(J) | 4K | — | $0 |
| Mar 20, 2026 | Hagen Brett R | Chief Accounting Officer | Sell(S) | 2K | $6.72 | $13K |
| Mar 19, 2026 | Feinsod Matthew | Chief Medical Officer | Grant(A) | 135K | — | $0 |
| Mar 19, 2026 | Gall Matthew | Chief Financial Officer | Grant(A) | 95K | — | $0 |
| Mar 19, 2026 | Oxtoby Andrew | See Remarks, Director | Grant(A) | 222K | — | $0 |
| Mar 19, 2026 | Hagen Brett R | Chief Accounting Officer | Grant(A) | 61K | — | $0 |
| Dec 22, 2025 | Akkaraju Srinivas | Director, 10% Owner | Grant(A) | 1.5M | $10.00 | $15.0M |
| Dec 18, 2025 | Samsara Opportunity Fund, L.P. | 10% Owner | Buy(P) | 480K | $10.42 | $5.0M |
| Nov 3, 2025 | Gall Matthew | Chief Financial Officer | Grant(A) | 235K | — | $0 |
| Apr 10, 2025 | Hallal David | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Patterson Leone D | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Feinsod Matthew | Chief Medical Officer | Grant(A) | 71K | — | $0 |
| Apr 10, 2025 | Feinsod Matthew | Chief Medical Officer | Grant(A) | 101K | — | $0 |
| Apr 10, 2025 | Adamis Anthony P | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Oxtoby Andrew | See Remarks, Director | Grant(A) | 287K | — | $0 |
| Apr 10, 2025 | Dybbs Michael | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Ferrara Napoleone | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Patel Samir Chandrakant | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Jovan-Embiricos Morana | Director | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Akkaraju Srinivas | Director, 10% Owner | Grant(A) | 18K | — | $0 |
| Apr 10, 2025 | Hagen Brett R | Chief Accounting Officer | Grant(A) | 50K | — | $0 |
| Mar 26, 2025 | Hagen Brett R | Chief Accounting Officer | Sell(S) | 907 | $8.97 | $8K |
| Mar 18, 2025 | Adamis Anthony P | Director | Grant(A) | 13K | — | — |
| Mar 18, 2025 | Adamis Anthony P | Director | Grant(A) | 19K | — | — |
| Mar 18, 2025 | Akkaraju Srinivas | Director, 10% Owner | Grant(A) | 11.4M | — | — |
| Mar 18, 2025 | Oxtoby Andrew | See Remarks, Director | Grant(A) | 477K | — | — |
| Mar 18, 2025 | Feinsod Matthew | Chief Medical Officer | Grant(A) | 4K | — | — |
| Mar 18, 2025 | Feinsod Matthew | Chief Medical Officer | Grant(A) | 28K | — | — |
| Mar 18, 2025 | Patel Samir Chandrakant | Director | Grant(A) | 101K | — | — |
| Mar 18, 2025 | Patel Samir Chandrakant | Director | Grant(A) | 252K | — | — |
| Mar 18, 2025 | Patel Samir Chandrakant | Director | Grant(A) | 106K | — | — |
| Mar 18, 2025 | Ferrara Napoleone | Director | Grant(A) | 504K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).